NASDAQ · MYCN

SSGA Active Trust State Street My2034 Corporate Bond ETF (MYCN)

$23.22−0.59%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$23.22▼ 6.95% in range
Sep 29, 2025Low $23.22 · High $25.20Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

SSGA Active Trust State Street My2034 Corporate Bond ETF closed at $23.22 on Sep 28, down 0.59%, within 0.0% of its 52-week closing low. Volume of 637 shares was 3.73× its 20-day average (well above normal).

Split-adjusted performance: -3.8% over one month, -4.3% over six months, -6.6% over one year.

Short interest was 464 shares at the Sep 15 settlement, up 25.1% from the prior report (2.5 days to cover).

Market cap$9.3M400.0K shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield5.35%$0.1036 last paid
52-week range23.22 – 25.20−7.8% from high
Volume6373.73× 20-day avg
Volatility · 60d5.1%Annualised
Short % of float—2.5 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −2.0%1M −3.8%3M −5.7%6M −4.3%YTD −6.4%1Y −6.6%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short464+25.1% vs prior
Days to cover2.5Settled Sep 15
% of float—
Short vol. 10d66.2%of daily volume

News about SSGA Active Trust State Street My2034 Corporate Bond ETF

All news →

No recent articles focused on SSGA Active Trust State Street My2034 Corporate Bond ETF.

Quick answers

What is MYCN's market cap?
$9.29M, based on the Sep 28 close of $23.22.
Does SSGA Active Trust State Street My2034 Corporate Bond ETF pay a dividend?
Yes. The latest regular dividend was $0.1036 per share (ex-date Sep 1), an annualised yield of 5.35%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology